 |
 |

Changes in the Treatment of Depression in the United States: 1987-1997
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Olfson and colleagues1 report a 3-fold increase in population-wide treatment of depression in the United States between 1987 and 1997. The authors present some possible reasons for this increase in their conclusions, specifically the introduction of selective serotonin reuptake inhibitors (SSRIs), aggressive pharmaceutical industry advertising, public health educational efforts, and better available screening instruments.
I wonder if the common denominator here is better diagnosis and treatment of depression in the primary care setting. This would also account for the increase in treatment by physicians that Olfson et al noted. I suspect that referral to psychiatrists has not become appreciably less laden with stigma or more affordable, but rather that the increased treatment is most likely due to nonpsychiatric physicians becoming more willing and adept at detecting and treating depression.
Having said that, I think that the authors' definition of psychotherapy as any "psychotherapy/mental health counseling" may . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
National Trends in the Outpatient Treatment of Depression
Mark Olfson, Steven C. Marcus, Benjamin Druss, Lynn Elinson, Terri Tanielian, and Harold Alan Pincus
JAMA. 2002;287(2):203-209.
ABSTRACT
| FULL TEXT
Prescribing Trends in Psychotropic Medications: Primary Care, Psychiatry, and Other Medical Specialties
Harold Alan Pincus, Terri L. Tanielian, Steven C. Marcus, Mark Olfson, Deborah A. Zarin, James Thompson, and Julie Magno Zito
JAMA. 1998;279(7):526-531.
ABSTRACT
| FULL TEXT
|